Literature DB >> 11035798

Phosphorylation of murine p53 at ser-18 regulates the p53 responses to DNA damage.

C Chao1, S Saito, C W Anderson, E Appella, Y Xu.   

Abstract

Ser-15 of human p53 (corresponding to Ser-18 of mouse p53) is phosphorylated by ataxia-telangiectasia mutated (ATM) family kinases in response to ionizing radiation (IR) and UV light. To determine the effects of phosphorylation of endogenous murine p53 at Ser-18 on biological responses to DNA damage, we introduced a missense mutation (Ser-18 to Ala) by homologous recombination into both alleles of the endogenous p53 gene in mouse embryonic stem (ES) cells. Our analyses showed that phosphorylation of murine p53 at Ser-18 in response to IR or UV radiation was required for a full p53-mediated response to these DNA damage-inducing agents. In contrast, phosphorylation of p53 at Ser-18 was not required for ATM-dependent cellular resistance after exposure to IR. Additionally, efficient acetylation of the C terminus of p53 in response to DNA damage did not require phosphorylation of murine p53 at Ser-18.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035798      PMCID: PMC17273          DOI: 10.1073/pnas.220252297

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Mechanisms of switching on p53: a role for covalent modification?

Authors:  D W Meek
Journal:  Oncogene       Date:  1999-12-13       Impact factor: 9.867

2.  DNA damage-induced activation of p53 by the checkpoint kinase Chk2.

Authors:  A Hirao; Y Y Kong; S Matsuoka; A Wakeham; J Ruland; H Yoshida; D Liu; S J Elledge; T W Mak
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

3.  p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage.

Authors:  C Chao; S Saito; J Kang; C W Anderson; E Appella; Y Xu
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

Review 4.  Signaling to p53: breaking the posttranslational modification code.

Authors:  E Appella; C W Anderson
Journal:  Pathol Biol (Paris)       Date:  2000-04

5.  DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage.

Authors:  G S Jimenez; F Bryntesson; M I Torres-Arzayus; A Priestley; M Beeche; S Saito; K Sakaguchi; E Appella; P A Jeggo; G E Taccioli; G M Wahl; M Hubank
Journal:  Nature       Date:  1999-07-01       Impact factor: 49.962

6.  The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.

Authors:  S Y Shieh; J Ahn; K Tamai; Y Taya; C Prives
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

7.  Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.

Authors:  N H Chehab; A Malikzay; M Appel; T D Halazonetis
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

8.  Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2.

Authors:  N Dumaz; D W Meek
Journal:  EMBO J       Date:  1999-12-15       Impact factor: 11.598

9.  Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53.

Authors:  S P Lees-Miller; K Sakaguchi; S J Ullrich; E Appella; C W Anderson
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

10.  Analysis of the gene coding for the murine cellular tumour antigen p53.

Authors:  B Bienz; R Zakut-Houri; D Givol; M Oren
Journal:  EMBO J       Date:  1984-09       Impact factor: 11.598

View more
  57 in total

1.  Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance.

Authors:  Eric J Brown; David Baltimore
Journal:  Genes Dev       Date:  2003-03-01       Impact factor: 11.361

Review 2.  Cellular senescence in cancer treatment: friend or foe?

Authors:  Pascal Kahlem; Bernd Dörken; Clemens A Schmitt
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

3.  Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription.

Authors:  Hiroyuki Takai; Kazuhito Naka; Yuki Okada; Miho Watanabe; Naoki Harada; Shin'ichi Saito; Carl W Anderson; Ettore Appella; Makoto Nakanishi; Hiroshi Suzuki; Kazuo Nagashima; Hirofumi Sawa; Kyoji Ikeda; Noboru Motoyama
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

4.  Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage.

Authors:  Connie Chao; Zhiqun Wu; Sharlyn J Mazur; Helena Borges; Matteo Rossi; Tongxiang Lin; Jean Y J Wang; Carl W Anderson; Ettore Appella; Yang Xu
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

5.  Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity.

Authors:  Lijin Feng; Tongxiang Lin; Hiroaki Uranishi; Wei Gu; Yang Xu
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

Review 6.  A proteomic primer for the clinician.

Authors:  Yurong Guo; Zongming Fu; Jennifer E Van Eyk
Journal:  Proc Am Thorac Soc       Date:  2007-01

7.  Altered mammary gland development in the p53+/m mouse, a model of accelerated aging.

Authors:  Catherine E Gatza; Melissa Dumble; Frances Kittrell; David G Edwards; Robert K Dearth; Adrian V Lee; Jianming Xu; Daniel Medina; Lawrence A Donehower
Journal:  Dev Biol       Date:  2007-10-12       Impact factor: 3.582

8.  Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53/p21-mediated growth arrest response.

Authors:  Jonathan P Castillo; Fiona M Frame; Harry A Rogoff; Mary T Pickering; Andrew D Yurochko; Timothy F Kowalik
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Identification and characterization of a potent activator of p53-independent cellular senescence via a small-molecule screen for modifiers of the integrated stress response.

Authors:  Carly M Sayers; Ioanna Papandreou; David M Guttmann; Nancy L Maas; J Alan Diehl; Eric S Witze; Albert C Koong; Constantinos Koumenis
Journal:  Mol Pharmacol       Date:  2012-12-10       Impact factor: 4.436

10.  p53: a molecular marker for the detection of cancer.

Authors:  Mark T Boyd; Nikolina Vlatkovic
Journal:  Expert Opin Med Diagn       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.